share_log

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schuyler Kevin

SEC ·  Mar 28 06:10
Summary by Futu AI
In a recent transaction dated 03/25/2024, Schuyler Kevin engaged in a stock market activity involving Adial Pharmaceuticals, Inc. (ADIL). The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the resulting total value of shares held by Schuyler Kevin after the action, have not been disclosed. The relationship of Schuyler Kevin to the issuer, Adial Pharmaceuticals, was not specified in the announcement.
In a recent transaction dated 03/25/2024, Schuyler Kevin engaged in a stock market activity involving Adial Pharmaceuticals, Inc. (ADIL). The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the resulting total value of shares held by Schuyler Kevin after the action, have not been disclosed. The relationship of Schuyler Kevin to the issuer, Adial Pharmaceuticals, was not specified in the announcement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.